Vernakalant Hydrochloride: A Novel Atrial-selective Agent for the Cardioversion of Recent-onset Atrial Fibrillation in the Emergency Department (vol 17, pg 1175, 2010)

被引：0
|
作者：
Stiell
机构：
来源：
ACADEMIC EMERGENCY MEDICINE | 2011年 / 18卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [31] Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation
    Ma, Wenfang
    Guo, Xiying
    Wang, Qixian
    Sun, Guihu
    Wang, Jie
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (01) : 32 - 41
  • [32] The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department
    Hamilton, Ailsa
    Clark, Donna
    Gray, Alasdair
    Cragg, Aidan
    Grubb, Neill
    EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2015, 22 (03) : 155 - 161
  • [33] An International View of How Recent-onset Atrial Fibrillation Is Treated in the Emergency Department
    Rogenstein, Carly
    Kelly, Anne-Maree
    Mason, Suzanne
    Schneider, Sandra
    Lang, Eddy
    Clement, Catherine M.
    Stiell, Ian G.
    ACADEMIC EMERGENCY MEDICINE, 2012, 19 (11) : 1255 - 1260
  • [34] Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department
    Simon, Alexander
    Niederdoeckl, Jan
    Skyllouriotis, Ekaterini
    Schuetz, Nikola
    Herkner, Harald
    Weiser, Christoph
    Laggner, Anton N.
    Domanovits, Hans
    Spiel, Alexander O.
    EUROPACE, 2017, 19 (02): : 233 - 240
  • [35] Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation (vol 71, pg 237, 2011)
    Atar, D.
    Banach, M.
    Ehrlich, J. R.
    Fedida, D.
    Lip, G. Y. H.
    Savelieva, I.
    DRUGS, 2011, 71 (03) : 381 - 381
  • [36] Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion
    Domanovits, H
    Schillinger, M
    Thoennissen, J
    Nikfardjam, M
    Janata, K
    Brunner, M
    Laggner, AN
    RESUSCITATION, 2000, 45 (03) : 181 - 187
  • [37] Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department: A Systematic Review and Network Meta-analysis
    deSouza, Ian S.
    Tadrous, Mina
    Sexton, Theresa
    Benabbas, Roshanak
    Carmelli, Guy
    Sinert, Richard
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (01) : 14 - 30
  • [38] Safety and efficacy of pharmacological cardioversion of recent onset atrial fibrillation in a major viennese emergency department
    Kriz, R.
    Weiss, T.
    Freynhofer, M.
    Huber, K.
    Koch, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S44 - S45
  • [39] Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals
    Stiell, Ian G.
    Clement, Catherine M.
    Rowe, Brian H.
    Brison, Robert J.
    Wyse, D. George
    Birnie, David
    Dorian, Paul
    Lang, Eddy
    Perry, Jeffrey J.
    Borgundvaag, Bjug
    Eagles, Debra
    Redfearn, Damian
    Brinkhurst, Jennifer
    Wells, George A.
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (05) : 562 - 571
  • [40] Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates
    Blecher, Gabriel E.
    Stiell, Ian G.
    Rowe, Brian H.
    Lang, Eddy
    Brison, Robert J.
    Perry, Jeffrey J.
    Clement, Catherine M.
    Borgundvaag, Bjug
    Langhan, Trevor
    Magee, Kirk
    Stenstrom, Rob
    Birnie, David
    Wells, George A.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2012, 14 (03) : 169 - 177
12345